ANDREW LEE to Carbonic Anhydrase Inhibitors
This is a "connection" page, showing publications ANDREW LEE has written about Carbonic Anhydrase Inhibitors.
Connection Strength
1.831
-
Assessing the Risk of Kidney Stone Development in Patients With Idiopathic Intracranial Hypertension Treated With Carbonic Anhydrase Inhibitors. J Neuroophthalmol. 2025 12 01; 45(4):420-425.
Score: 0.885
-
Fulminant idiopathic intracranial hypertension managed with oral acetazolamide. Can J Ophthalmol. 2016 Aug; 51(4):e121-e125.
Score: 0.490
-
The use of acetazolamide in idiopathic intracranial hypertension during pregnancy. Am J Ophthalmol. 2005 May; 139(5):855-9.
Score: 0.227
-
McArdle Disease Rhabdomyolysis Precipitated by Acetazolamide for Idiopathic Intracranial Hypertension. J Neuroophthalmol. 2023 12 01; 43(4):e159-e160.
Score: 0.184
-
Sleep apnea and intracranial hypertension in men. Ophthalmology. 2002 Mar; 109(3):482-5.
Score: 0.045